Vimarsana
Biggest News Aggregation in the World

Page 3 - Technology Research Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Research Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Research Network Today - Breaking & Trending Today

Northwestern spinoff receives $21.3M from NIH to manufacture COVID-19 test - Vimarsana News

Northwestern spinoff receives $21.3M from NIH to manufacture COVID-19 test

Northwestern spinoff receives $21.3M from NIH to manufacture COVID-19 test Highly sensitive PCR test takes 15 minutes, using cereal box-sized device A user inserts a small cartridge, holding a nasal swab sample, into a DASH system. A new, highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received $21.3 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx SM) initiative. Developed at Northwestern University’s Center for Innovation in Global Health Technologies (CIGHT), the point-of-care technology is being...

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort - Vimarsana News

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort Share: Insights, lessons learned after a year of transforming COVID-19 testing—a special journal issue One-year into implementation of the National Institutes of Health’s Rapid Acceleration of Diagnostics (RADx) initiative, the Institute of Electrical and Electronics Engineers (IEEE) Open Journal of Engineering in Medicine and Biology has dedicated a special April 29...

Source: nih.gov
NIH to evaluate COVID-19 at-home testing system - Vimarsana News

NIH to evaluate COVID-19 at-home testing system

HIN A research team funded by the National Institutes of Health has launched a study to assess performance and usability of a smartphone app paired with the Quidel QuickVue At-Home COVID-19 Test, which just received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for use with a prescription. The home test was supported by NIH through the Rapid Acceleration of Diagnostics (RADx) initiative, which has spurred the development and commercial availability of millions of COVID-19 tests over the past year. More than 200 participants have already enrolled in the study ...

Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the ... - Vimarsana News

Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the ... Meridian Bioscience Inc.February 3, 2021 GMT CINCINNATI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it will increase production capacity of the company’s SARS-CoV-2 molecular diagnostic test on its Revogene® platform after receiving a $5.5M award from the National Institute of H...

Source: apnews.com
Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown - Vimarsana News

Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown

Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown February 03, 2021 10:30 ET | Source: Meridian Bioscience Inc. Meridian Bioscience Inc. Cincinnati, Ohio, UNITED STATES CINCINNATI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it will increase production capacity of the company's SARS-CoV-2 molecular diagnostic test on its Revogene ® platform after receiving a $5.5M...